Neuronal PAS Domain Protein 1 (NPAS1) (Middle Region) Peptide
-
- Target See all NPAS1 products
- NPAS1 (Neuronal PAS Domain Protein 1 (NPAS1))
- Protein Region
- Middle Region
- Origin
- Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LPAIVSQEEP SRPGPEPTEE EPPVDGKQAV PADQDKDKDP QARGKRIKVE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Npas1 Antibody(ARP36951_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NPAS1 (Neuronal PAS Domain Protein 1 (NPAS1))
- Synonyms
- si:dkeyp-13e2.1 Peptide, MOP5 Peptide, PASD5 Peptide, bHLHe11 Peptide, neuronal PAS domain protein 1 Peptide, npas1 Peptide, NPAS1 Peptide, Npas1 Peptide
- Background
-
Npas1 may control regulatory pathways relevant to schizophrenia and to psychotic illness.Npas1 may play a role in late central nervous system development by modulating EPO expression in response to cellular oxygen level.
Alias Symbols: MOP5, bHLHe11
Protein Interaction Partner: Arnt,Epo
Protein Size: 594 - Molecular Weight
- 64 kDa
- Gene ID
- 18142
- NCBI Accession
- NM_008718, NP_032744
- UniProt
- P97459
-